These coincidences keep popping up. Monkeypox has arrived in just enough time to save two American smallpox vaccine companies. Just two weeks ago, both corrupt Big Pharma companies were in a rough financial spot.
As concerns over the monkeypox grow following the fear-mongering of the ruling class and the mainstream media, so too have the shares of Emergent Biosolutions and SIGA Technologies. Both companies essentially have monopolies in the US market, and other markets as well, on smallpox vaccines and treatments. Their main smallpox-focused products are, conveniently, also used to protect against or treat monkeypox as well. As a result, the shares of Emergent Biosolutions climbed 12% on Thursday, while those of SIGA soared 17.1%, according to a report by the Daily Exposé.
The monkeypox outbreak is especially good for SIGA, which produces a smallpox treatment, known by its brand name TPOXX. It is SIGA’s only product. While some outlets have noted that the rise in the valuation of SIGA Technologies has coincided with recent concerns about monkeypox, essentially no attention has been given to the fact that the company is apparently the only piece of a powerful billionaire’s empire that isn’t currently crumbling.